Tetratherix Ltd Cash Flow Conversion Efficiency
Tetratherix Ltd cash flow conversion efficiency. Based on the latest financial reports, Tetratherix Ltd (TTX) has a cash flow conversion efficiency ratio of -0.186x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-4.53 Million ≈ $-3.21 Million USD) by net assets (AU$24.37 Million ≈ $17.24 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Tetratherix Ltd (2023–2025)
Cash flow conversion efficiency of Tetratherix Ltd from 2023 to 2025. This chart illustrates how Tetratherix Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for Tetratherix Ltd for real-time trading data and today's change.
Tetratherix Ltd Cash Flow Conversion Ratio Explained
Tetratherix Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Tetratherix Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Tetratherix Ltd ranked by their cash flow conversion efficiency. Also see market value of Tetratherix Ltd for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Sichuan Dowell Science and Technology Inc
SHE:300535
|
0.004x |
|
Iberpapel Gestion SA
MC:IBG
|
0.040x |
|
Kolibri Global Energy Inc. Common stock
NASDAQ:KGEI
|
0.053x |
|
Motorcar Parts of America Inc
NASDAQ:MPAA
|
-0.032x |
|
BAJEL PROJECTS LTD
NSE:BAJEL
|
0.009x |
|
GTM Holdings Corp
TW:1437
|
-0.002x |
|
Politeknik Metal Sanayi ve
IS:POLTK
|
0.228x |
|
Fibra Inn
MX:FINN13
|
-0.011x |
Annual Cash Flow Conversion Efficiency for Tetratherix Ltd (2023–2025)
The table below shows the annual cash flow conversion efficiency of Tetratherix Ltd from 2023 to 2025. Review Tetratherix Ltd (TTX) flexibility index to assess the company's free cash flow relative to its total liabilities.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | AU$27.25 Million ≈ $19.28 Million |
AU$-2.67 Million ≈ $-1.89 Million |
-0.098x | -125.96% |
| 2024-06-30 | AU$-6.78 Million ≈ $-4.80 Million |
AU$-2.56 Million ≈ $-1.81 Million |
0.378x | +343.15% |
| 2023-06-30 | AU$-4.56 Million ≈ $-3.22 Million |
AU$-388.24K ≈ $-274.70K |
0.085x | -- |
About Tetratherix Ltd
Tetratherix Limited engages in biomaterial and regenerative medicine business in Australia and internationally. The company manufactures and commercialize medical device in the areas of bone regeneration, tissue spacing, and tissue healing applications through its Tetramatrix platform technology. Tetratherix Limited was incorporated in 2015 and is based in Alexandria, Australia.